Western University Of Health Sciences;Tesorx Pharma, LLC
发明人:
申请号：
EP17736520.2
公开号：
EP3399965A4
申请日:
2017.01.09
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Novel testosterone undecanoate (TU) formulations are disclosed in which TU is incorporated into proliposomal powder dispersions of TU and distearoyl phosphatidylcholine (DSPC). The proliposomal powder dispersions of the invention can also be combined with pharmaceutically acceptable excipients, and incorporated into enterically coated oral dosage forms that are useful for testosterone replacement therapy.
